Report Content
Chapter 1 Methodology
1.1 Methodology
1.2 Base estimates & working
1.3 Forecast calculations
1.4 Data validation
1.5 Data Sources
1.5.1 Secondary
1.5.1.1 Paid Sources
1.5.1.2 Unpaid Sources
1.5.2 Primary
Chapter 2 Executive Summary
2.1 Magnetic beads industry 3600 synopsis, 2016 – 2027
2.1.1 Business trends
2.1.2 Type trends
2.1.3 Application trends
2.1.4 End-use trends
2.1.5 Regional trends
Chapter 3 Magnetic Beads Industry Insights
3.1 Industry segmentation
3.2 Industry landscape, 2016 – 2027
3.3 Industry impact forces
3.3.1 Growth drivers
3.3.1.1 Increasing application of magnetic beads in medical field
3.3.1.2 Rising preference for in-vitro diagnostic testing
3.3.1.3 Increasing funding for cell-based research by biotechnology companies and government bodies across the globe
3.3.1.4 Technological advancements in magnetic beads market
3.3.2 Industry pitfalls and challenges
3.3.2.1 High cost associated with genetic research in developing countries
3.4 Growth potential analysis
3.4.1 By type
3.4.2 By application
3.4.3 By end-use
3.5 COVID-19 impact analysis
3.6 Porter’s analysis
3.7 PESTEL analysis
3.8 Competitive landscape, 2020
3.8.1 Company matrix analysis, 2020
Chapter 4 Magnetic Beads Market, By Type
4.1 Key segment trends
4.2 Cells & microbes
4.2.1 Market size, by region, 2016 – 2027
4.3 Nucleic acid
4.3.1 Market size, by region, 2016 – 2027
4.4 Proteins
4.4.1 Market size, by region, 2016 – 2027
4.5 Others
4.5.1 Market size, by region, 2016 – 2027
Chapter 5 Magnetic Beads Market, By Application
5.1 Key segment trends
5.2 Cell separation & expansion
5.2.1 Market size, by region, 2016 – 2027
5.3 Protein sample preparation & protein purification
5.3.1 Market size, by region, 2016 – 2027
5.4 IVD assay development
5.4.1 Market size, by region, 2016 – 2027
5.5 Nucleic acid isolation
5.5.1 Market size, by region, 2016 – 2027
5.6 Immunoprecipitation
5.6.1 Market size, by region, 2016 – 2027
5.7 Exosome analysis
5.7.1 Market size, by region, 2016 – 2027
5.8 Antibody purification
5.8.1 Market size, by region, 2016 – 2027
5.9 Others
5.9.1 Market size, by region, 2016 – 2027
Chapter 6 Magnetic Beads Market, By End-use
6.1 Key segment trends
6.2 Healthcare facilities
6.2.1 Market size, by region, 2016 – 2027
6.3 Individual pathology labs
6.3.1 Market size, by region, 2016 – 2027
6.4 Research labs
6.4.1 Market size, by region, 2016 – 2027
6.5 Others
6.5.1 Market size, by region, 2016 – 2027
Chapter 7 Magnetic Beads Market, By Region
7.1 Key regional trends
7.2 North America
7.2.1 Market size, by country, 2016 – 2027
7.2.2 Market size, by type, 2016 – 2027
7.2.3 Market size, by application, 2016 – 2027
7.2.4 Market size, by end-use, 2016 – 2027
7.2.5 U.S.
7.2.5.1 Market size, by type, 2016 – 2027
7.2.5.2 Market size, by application, 2016 – 2027
7.2.5.3 Market size, by end-use, 2016 – 2027
7.2.6 Canada
7.2.6.1 Market size, by type, 2016 – 2027
7.2.6.2 Market size, by application, 2016 – 2027
7.2.6.3 Market size, by end-use, 2016 – 2027
7.3 Europe
7.3.1 Market size, by country, 2016 – 2027
7.3.2 Market size, by type, 2016 – 2027
7.3.3 Market size, by application, 2016 – 2027
7.3.4 Market size, by end-use, 2016 – 2027
7.3.5 Germany
7.3.5.1 Market size, by type, 2016 – 2027
7.3.5.2 Market size, by application, 2016 – 2027
7.3.5.3 Market size, by end-use, 2016 – 2027
7.3.6 UK
7.3.6.1 Market size, by type, 2016 – 2027
7.3.6.2 Market size, by application, 2016 – 2027
7.3.6.3 Market size, by end-use, 2016 – 2027
7.3.7 France
7.3.7.1 Market size, by type, 2016 – 2027
7.3.7.2 Market size, by application, 2016 – 2027
7.3.7.3 Market size, by end-use, 2016 – 2027
7.3.8 Italy
7.3.8.1 Market size, by type, 2016 – 2027
7.3.8.2 Market size, by application, 2016 – 2027
7.3.8.3 Market size, by end-use, 2016 – 2027
7.3.9 Spain
7.3.9.1 Market size, by type, 2016 – 2027
7.3.9.2 Market size, by application, 2016 – 2027
7.3.9.3 Market size, by end-use, 2016 – 2027
7.4 Asia Pacific
7.4.1 Market size, by country, 2016 – 2027
7.4.2 Market size, by type, 2016 – 2027
7.4.3 Market size, by application, 2016 – 2027
7.4.4 Market size, by end-use, 2016 – 2027
7.4.5 Japan
7.4.5.1 Market size, by type, 2016 – 2027
7.4.5.2 Market size, by application, 2016 – 2027
7.4.5.3 Market size, by end-use, 2016 – 2027
7.4.6 China
7.4.6.1 Market size, by type, 2016 – 2027
7.4.6.2 Market size, by application, 2016 – 2027
7.4.6.3 Market size, by end-use, 2016 – 2027
7.4.7 India
7.4.7.1 Market size, by type, 2016 – 2027
7.4.7.2 Market size, by application, 2016 – 2027
7.4.7.3 Market size, by end-use, 2016 – 2027
7.4.8 Australia
7.4.8.1 Market size, by type, 2016 – 2027
7.4.8.2 Market size, by application, 2016 – 2027
7.4.8.3 Market size, by end-use, 2016 – 2027
7.5 Latin America
7.5.1 Market size, by country, 2016 – 2027
7.5.2 Market size, by type, 2016 – 2027
7.5.3 Market size, by application, 2016 – 2027
7.5.4 Market size, by end-use, 2016 – 2027
7.5.5 Brazil
7.5.5.1 Market size, by type, 2016 – 2027
7.5.5.2 Market size, by application, 2016 – 2027
7.5.5.3 Market size, by end-use, 2016 – 2027
7.5.6 Mexico
7.5.6.1 Market size, by type, 2016 – 2027
7.5.6.2 Market size, by application, 2016 – 2027
7.5.6.3 Market size, by end-use, 2016 – 2027
7.5.7 Argentina
7.5.7.1 Market size, by type, 2016 – 2027
7.5.7.2 Market size, by application, 2016 – 2027
7.5.7.3 Market size, by end-use, 2016 – 2027
7.6 MEA
7.6.1 Market size, by country, 2016 – 2027
7.6.2 Market size, by type, 2016 – 2027
7.6.3 Market size, by application, 2016 – 2027
7.6.4 Market size, by end-use, 2016 – 2027
7.6.5 South Africa
7.6.5.1 Market size, by type, 2016 – 2027
7.6.5.2 Market size, by application, 2016 – 2027
7.6.5.3 Market size, by end-use, 2016 – 2027
7.6.6 Saudi Arabia
7.6.6.1 Market size, by type, 2016 – 2027
7.6.6.2 Market size, by application, 2016 – 2027
7.6.6.3 Market size, by end-use, 2016 – 2027
7.6.7 UAE
7.6.7.1 Market size, by type, 2016 – 2027
7.6.7.2 Market size, by application, 2016 – 2027
7.6.7.3 Market size, by end-use, 2016 – 2027
Chapter 8 Company Profiles
8.1 Strategy dashboard, 2020
8.2 Abraxis, Inc
8.2.1 Business Overview
8.2.2 Financial data
8.2.3 Product landscape
8.2.4 Strategic outlook
8.2.5 SWOT analysis
8.3 Bangs Laboratories Inc
8.3.1 Business overview
8.3.2 Financial data
8.3.3 Product landscape
8.3.4 SWOT analysis
8.4 Bio-Rad Laboratories
8.4.1 Business Overview
8.4.2 Financial data
8.4.3 Product Landscape
8.4.4 SWOT analysis
8.5 Cardiogenics Inc
8.5.1 Business overview
8.5.2 Product landscape
8.5.3 SWOT analysis
8.6 Danaher Corporation
8.6.1 Business overview
8.6.2 Financial data
8.6.3 Product landscape
8.6.4 Strategic outlook
8.6.5 SWOT analysis
8.7 Geneaid Biotech Ltd
8.7.1 Business Overview
8.7.2 Financial data
8.7.3 Product landscape
8.7.4 SWOT analysis
8.8 GenScript Corporation
8.8.1 Business overview
8.8.2 Financial data
8.8.3 Product landscape
8.8.4 Strategic outlook
8.8.5 SWOT analysis
8.9 Merck Millipore (Merck KGaA)
8.9.1 Business overview
8.9.2 Financial data
8.9.3 Product landscape
8.9.4 SWOT analysis
8.10 Micromod Partikeltechnologie GmbH
8.10.1 Business Overview
8.10.2 Financial data
8.10.3 Product Landscape
8.10.4 SWOT analysis
8.11 Miltenyi Biotec
8.11.1 Business Overview
8.11.2 Financial data
8.11.3 Product Landscape
8.11.4 Strategy outlook
8.11.5 SWOT analysis
8.12 New England Biolabs
8.12.1 Business Overview
8.12.2 Financial data
8.12.3 Product landscape
8.12.4 SWOT analysis
8.13 Promega Corporation
8.13.1 Business overview
8.13.2 Financial data
8.13.3 Product landscape
8.13.4 SWOT analysis
8.14 Qiagen
8.14.1 Business Overview
8.14.2 Financial data
8.14.3 Product Landscape
8.14.4 SWOT analysis
8.15 Rockland Immunochemicals, Inc.
8.15.1 Business overview
8.15.2 Financial data
8.15.3 Product landscape
8.15.4 SWOT analysis
8.16 Spherotech, Inc.
8.16.1 Business overview
8.16.2 Financial data
8.16.3 Product landscape
8.16.4 SWOT analysis
8.17 Takara Bio Inc
8.17.1 Business overview
8.17.2 Financial data
8.17.3 Product landscape
8.17.4 SWOT analysis
8.18 Thermo Fisher Scientific
8.18.1 Business Overview
8.18.2 Financial data
8.18.3 Product landscape
8.18.4 SWOT analysis
